BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Sullivan KE, Hurley ET, Hurley JP. Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival. Gastroenterol Res Pract 2015;2015:518281. [PMID: 26246803 DOI: 10.1155/2015/518281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Rasmussen SR, Nielsen RV, Fenger AS, Siemsen M, Ravn HB. Postoperative complications and survival after surgical resection of esophageal squamous cell carcinoma. J Thorac Dis 2018;10:4052-60. [PMID: 30174848 DOI: 10.21037/jtd.2018.07.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Imai T, Abe T, Uemura N, Yoshida K, Shimizu Y. Immediate extubation after esophagectomy with three-field lymphadenectomy enables early ambulation in patients with thoracic esophageal cancer. Esophagus 2018;15:165-72. [PMID: 29951981 DOI: 10.1007/s10388-018-0608-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhang J, Li S, Shang Z, Lin S, Gao P, Zhang Y, Hou S, Mo S, Cao W, Dong Z, Hu T, Chen P. Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells. Oncotarget 2017;8:29125-37. [PMID: 28418860 DOI: 10.18632/oncotarget.16250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
4 Babar L, Kosovec JE, Jahangiri V, Chowdhury N, Zheng P, Omstead AN, Salvitti MS, Smith MA, Goel A, Kelly RJ, Jobe BA, Zaidi AH. Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma. Oncotarget 2019;10:4546-55. [PMID: 31360303 DOI: 10.18632/oncotarget.27052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Dias F, Morais M, Teixeira AL, Medeiros R. Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior. Cancers (Basel) 2018;10:E381. [PMID: 30322005 DOI: 10.3390/cancers10100381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Andreollo NA, Beraldo GC, Alves IPF, Tercioti-Junior V, Ferrer JAP, Coelho-Neto JS, Lopes LR. PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS. Arq Bras Cir Dig 2018;31:e1405. [PMID: 30539980 DOI: 10.1590/0102-672020180001e1405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Jin X, Zheng X, Chen D, Jin J, Zhu G, Deng X, Han C, Gong C, Zhou Y, Liu C, Xie C. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics. Eur Radiol. 2019;29:6080-6088. [PMID: 31028447 DOI: 10.1007/s00330-019-06193-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]